Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis

Table 3

Demographic and clinical data of the enrolled patients.

	(%)
Sex
Males	61 (87.1)
Females	9 (12.9)
Etiology of liver disease
Chronic hepatitis C	51 (72.9)
Chronic hepatitis B	12 (17.1)
Budd-Chiari syndrome	2 (2.9)
Unknown etiology	5 (7.1)
HCC
No	50 (71.4)
Yes	20 (28.6)
Ascites
No	9 (12.9)
Mild	23 (32.8)
Moderate	29 (41.4)
Marked	9 (12.9)
Child-Pugh class
B	18 (25.7)
C	52 (74.3)
Renal impairment
No (GFR ≥90 mL/min)	22 (31.4)
Early (GFR 60–89 mL/min)	45 (64.3)
Advanced (GFR 30–59 mL/min)	3 (4.3)

GFR, glomerular filtration rate; HCC, hepatocellular carcinoma.